2749 E. PARLEYS WAY, SALT LAKE CITY, UT
Reports Fourth Quarter 2025 Financial Results
Investor Presentation
Landmark Study Finds Blood Test Reduces Earliest Preterm Births and Newborn Complications
Announces Publication Acceptance for PRIME Study
Financial Results, Press Release
Reg. FD
Shareholder votes
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload